Birchview Capital’s Protagonist Therapeutics PTGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.65M | Sell |
48,000
-2
| -0% | -$111 | 2.63% | 9 |
|
|
2025
Q1 | $2.32M | Buy |
48,002
+2
| +0% | +$97 | 2.02% | 12 |
|
|
2024
Q4 | $1.85M | Hold |
48,000
| – | – | 1.51% | 19 |
|
|
2024
Q3 | $2.16M | Hold |
48,000
| – | – | 1.87% | 15 |
|
|
2024
Q2 | $1.66M | Hold |
48,000
| – | – | 1.54% | 18 |
|
|
2024
Q1 | $1.39M | Hold |
48,000
| – | – | 1.13% | 20 |
|
|
2023
Q4 | $1.1M | Buy |
48,000
+10,000
| +26% | +$229K | 0.86% | 25 |
|
|
2023
Q3 | $634K | Hold |
38,000
| – | – | 0.54% | 31 |
|
|
2023
Q2 | $1.05M | Hold |
38,000
| – | – | 0.79% | 23 |
|
|
2023
Q1 | $874K | Hold |
38,000
| – | – | 0.68% | 23 |
|
|
2022
Q4 | $415K | Hold |
38,000
| – | – | 0.29% | 37 |
|
|
2022
Q3 | $320K | Hold |
38,000
| – | – | 0.23% | 47 |
|
|
2022
Q2 | $301K | Hold |
38,000
| – | – | 0.22% | 47 |
|
|
2022
Q1 | $900K | Hold |
38,000
| – | – | 0.65% | 30 |
|
|
2021
Q4 | $1.3M | Hold |
38,000
| – | – | 0.84% | 23 |
|
|
2021
Q3 | $673K | Buy |
38,000
+28,000
| +280% | +$496K | 0.46% | 35 |
|
|
2021
Q2 | $449K | Hold |
10,000
| – | – | 0.27% | 45 |
|
|
2021
Q1 | $259K | Buy |
+10,000
| New | +$259K | 0.15% | 49 |
|